,id,study.name,effect.key,b,s,n,specialty,outcome.group,outcome.flag,outcome.nr,comparison.nr,RCT,study.year,outcome_name,comparison_name,z,gold_answer_GPT4,llama3-8b-8192,llama3-70b-8192,llama-3.1-70b-versatile,mixtral-8x7b-32768,gemma-7b-it,human_response,MV,llama3-8b-8192_cleaned,llama3-70b-8192_cleaned,llama-3.1-70b-versatile_cleaned,mixtral-8x7b-32768_cleaned,gemma-7b-it_cleaned,MV_cleaned,gold_answer_GPT4_cleaned,gemini-1.5-flash-002,gemini-1.5-flash-002_tokens,gemini-1.5-flash-002_logprobs,gemini-1.5-pro-002,gemini-1.5-flash-002_cleaned,gemini-1.5-pro-002_cleaned,meta-llama/Llama-3.2-1B-Instruct,meta-llama/Llama-3.2-1B-Instruct_cleaned,meta-llama/Llama-3.2-3B-Instruct,meta-llama/Llama-3.2-3B-Instruct_cleaned,meta-llama/Llama-3.2-1B-Instruct_probs,meta-llama/Llama-3.2-3B-Instruct_probs,microsoft/Phi-3.5-mini-instruct,google/gemma-2-2b-it,microsoft/Phi-3.5-mini-instruct_cleaned,google/gemma-2-2b-it_cleaned,microsoft/Phi-3.5-mini-instruct_probs,google/gemma-2-2b-it_probs,ibm-granite/granite-3.0-3b-a800m-instruct,ibm-granite/granite-3.0-2b-instruct,ibm-granite/granite-3.0-3b-a800m-instruct_cleaned,ibm-granite/granite-3.0-2b-instruct_cleaned,Qwen/Qwen2.5-3B-Instruct,Qwen/Qwen2.5-3B-Instruct_cleaned,ibm-granite/granite-3.0-3b-a800m-instruct_probs,ibm-granite/granite-3.0-2b-instruct_probs,Qwen/Qwen2.5-3B-Instruct_probs,llama3-8b-8192_MV_review,llama3-70b-8192_MV_review,llama-3.1-70b-versatile_MV_review,mixtral-8x7b-32768_MV_review,meta-llama/Llama-3.2-1B-Instruct_MV_review,meta-llama/Llama-3.2-3B-Instruct_MV_review,gemma-7b-it_MV_review,gemini-1.5-flash-002_MV_review,gemini-1.5-pro-002_MV_review,gold_answer_GPT4_MV_review,google/gemma-2-2b-it_MV_review,microsoft/Phi-3.5-mini-instruct_MV_review,ibm-granite/granite-3.0-3b-a800m-instruct_MV_review,ibm-granite/granite-3.0-2b-instruct_MV_review,Qwen/Qwen2.5-3B-Instruct_MV_review,MV_MV_review
0,CD000004,Blecher 1967,STD-Blecher-1967 0.362 0.353 42 38,-1.55227949859415,0.509869905232146,80,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1967.0,Unchanged or worsening pre-eclampsia,Abdominal decompression for suspected fetal compromise/pre-eclampsia,-3.04446189638785,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9981614395267993,"negative
",neg,neg,negative.,neg,negative,neg,0.6767524686179688,0.9711912386663372, negative,"negative 
",neg,neg,0.9465925965321365,0.8122987173222388,neutral. the,negative,neu,neg,negative,neg,0.5738107932693522,0.9734106869597751,0.9972122164353961,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg
1,CD000006,Banninger 1978,STD-Banninger-1978 0.441 0.282 80 73,-1.13370360847938,0.379196674468605,153,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1978.0,Short-term pain: pain at day 3 or less (women experiencing any pain),Synthetic sutures versus catgut,-2.9897509256064,negative,neutral,negative,negative.,"negative, as it refers","negative.

pain is",neg,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9947790259105216,"negative
",neg,neg,positive.,pos,negative,neg,0.4820626788760636,0.6145821267845748, negative,"positive 
",neg,pos,0.9764529852884616,0.3419215751723821,neutral. the,positive,neu,pos,negative,neg,0.44932877128619125,0.8660684234373706,0.925684138461235,neu,neg,neg,neg,pos,neg,neg,neg,neg,neg,pos,neu,neu,pos,neu,neg
2,CD000007,Abu Dhabi 1997,STD-Abu-Dhabi-1997 0.529 0.172 827 821,-0.692206245543344,0.18600035093523,1648,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1997.0,PPH clinically estimated blood loss greater than or equal to 500mls,Active vs expectant management (all women),-3.72153193293913,negative,negative,negative,negative.,negative,"negative.

a clinically",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.983214769476174,"negative
",neg,neg,negative.,neg,negative,neg,0.5262995173044033,0.8942198995096511, negative,"negative 
",neg,neg,0.99858936266873,0.5854551496207451,positive.,negative,pos,neg,negative,neg,0.4745139766936262,0.9381382453618513,0.9972793177712731,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
3,CD000009,Aycicegi-Dinn 2011,STD-Aycicegi_x002d_Dinn-2011 0.319 1.117 24 23,-1.23837423104327,1.19449219093425,47,Psychiatry & Mental Health,efficacy,DICH,1,8,no,2011.0,Short-term smoking cessation,Electrostimulation vs sham stimulation,-1.03673698366726,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9997544718169792,"positive
",pos,pos,positive.,pos,positive,pos,0.6020187943883959,0.6959193309325054, positive,"positive 
",pos,pos,0.977385557863118,0.8574970458563754,positive.,positive,pos,pos,positive,pos,0.5584962183901858,0.5649193281804056,0.991289503841217,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
4,CD000010,Kamolratanakul 1999,STD-Kamolratanakul-1999 1.135 0.044 414 422,0.446479824178497,0.154930393353026,836,Infectious Diseases,efficacy,DICH,1,5,no,1999.0,Cure,Active TB: Direct observation of treatment vs self-supervision,2.88180914354966,positive,positive,positive,positive,positive,"positive.

a cure",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9999254992953154,"positive
",pos,pos,negative.,neg,positive,pos,0.4042691789578895,0.6942233745366926, positive,"positive 
",pos,pos,0.9984953427388004,0.7876150266946763,positive.,positive,pos,pos,positive,pos,0.5219166100916729,0.8016942563364917,0.999686458709013,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
5,CD000012,Begley 2009,STD-Begley-2009 1.237 0.149 1059 549,0.240453099890958,0.16737008325693,1608,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,2009.0,No analgesia/anesthesia,Alternative versus conventional birth settings - all trials,1.43665519674647,neutral,neutral,negative,negative.,negative,"neutral.

the absence",pos,negative,neu,neg,neg,neg,neu,neg,neu,"negative
",negative,0.9868977279655562,"neutral
",neg,neu,negative.,neg,negative,neg,0.5011580854834997,0.6144761230660124," neutral

","neutral 
",neu,neu,0.5042667501758678,0.4776413043750637,neutral. the,negative.,neu,neg,negative,neg,0.5781812062744155,0.44503864657186143,0.8798841716904211,neu,neg,neg,neg,neg,neg,neu,neg,neu,neu,neu,neu,neu,neg,neg,neg
6,CD000013,Amin 2003,STD-Amin-2003 0.294 0.484 80 80,-1.39812881876689,0.536684151636802,160,Pregnancy & Childbirth,efficacy,DICH,1,1,no,2003.0,"Caesarean section, overall","Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM)*",-2.60512410232876,negative,negative,negative,negative.,negative,"negative.

caes",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9901411839211304,"negative
",neg,neg,negative.,neg,negative,neg,0.5053031749018777,0.7925072097697992, negative,"negative 
",neg,neg,0.9834115841632391,0.6578221066842471,the outcome ',negative,neg,neg,negative,neg,0.43061253573641867,0.9297240331209724,0.9783813006821853,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
7,CD000014,Choudhary 2010,STD-Choudhary-2010 0.043 1.015 146 146,-3.30004360297731,1.0288366701739,292,Pregnancy & Childbirth,efficacy,DICH,1,1,no,2010.0,Meconium aspiration syndrome,Amnioinfusion for meconium-stained liquor in labour,-3.20754858243876,negative,negative,negative,negative.,negative,"negative.

mecon",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9983516126852068,"negative
",neg,neg,negative.,neg,negative,neg,0.5365499871116614,0.9651195763852628, negative,"negative 
",neg,neg,0.983076211885032,0.873283354020754,positive. me,negative,pos,neg,negative,neg,0.37424463002358843,0.9866892474840055,0.9998190730386237,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
8,CD000015,Fraser 1993,STD-Fraser-1993 0.335 0.331 462 463,-1.21291884403288,0.387434539910941,925,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1991.0,Cessation of contractions,Amniotomy to shorten spontaneous labour,-3.13064200293473,negative,negative,negative,negative.,negative,"positive.

cess",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.9974882517317576,"negative
",neg,neg,positive.,pos,negative,neg,0.4096563329169349,0.4832255027532774, negative,"positive 
",neg,pos,0.9883093873942524,0.9307862759548552,the outcome ',negative,neg,neg,positive,pos,0.327413659023949,0.9613603125246911,0.4763296333728964,neg,neg,neg,neg,pos,neg,pos,neg,neg,neg,pos,neg,neg,neg,pos,neg
9,CD000016,Brazil 1983-84,STD-Brazil-1983_x002d_84 0.935 0.496 36 30,-0.0682082500265335,0.500032319576001,66,Infectious Diseases,efficacy,DICH,1,1,no,1983.0,Parasitological conversion,Amodiaquine vs chloroquine in symptomatic participants,-0.136407682776126,positive,neutral,positive,positive.,"negative, because paras","positive.

parasito",pos,negative,neu,pos,pos,neg,pos,neg,pos,"positive
",positive,0.9980932772098972,"positive
",pos,pos,positive,pos,negative,neg,0.3858461890111303,0.3925313699154665, neutral,"positive 
",neu,pos,0.8935026872565591,0.7697474827697053,positive. par,positive,pos,pos,neutral,neu,0.3774209925641084,0.8436574104564855,0.8867133464700865,neu,neg,pos,neg,pos,neg,pos,pos,pos,pos,pos,neu,pos,pos,neu,neg
10,CD000018,Amoroso 1998,STD-Amoroso-1998 0.332 0.663 389 388,-1.11691345305051,0.670577095080808,777,Emergency & Trauma,efficacy,DICH,1,1,no,1998.0,Ankle sprain by intervention type,Any intervention v no intervention/control,-1.66560036309609,negative,negative,negative,negative.,"negative, because an an","negative.

an ankle",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997387536307772,"negative
",neg,neg,negative.,neg,negative,neg,0.5785372768177786,0.9286068420899528, negative,"negative 
",neg,neg,0.9431169023612914,0.70962736599664,positive.,negative.,pos,neg,negative,neg,0.5019243331002697,0.6660984475089317,0.9961510601957447,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
11,CD000019,ACTOBAT 1995,STD-ACTOBAT-1995 1.229 0.179 699 698,0.224813869668154,0.194880886688445,1397,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1995.0,Death prior to hospital discharge,TRH + steroids versus steroids alone (intention-to-treat),1.15359629919769,negative,negative,negative,negative.,negative,"negative.

death prior",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9715637890010614,"negative
",neg,neg,negative.,neg,negative.,neg,0.582878752005497,0.8724127413856602, negative,"negative 
",neg,neg,0.9875478857804324,0.617561053341585,positive.,negative,pos,neg,negative,neg,0.24643249165045297,0.9873347127094716,0.9998464820072032,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
12,CD000020,Huchet 1987,STD-Huchet-1987 0.172 1.079 927 955,-1.76722490526431,1.08111068862228,1882,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Incidence of Rhesus D alloimmunisation during pregnancy,Anti-D administration in pregnancy,-1.63463826957106,negative,negative,negative,negative.,"negative, because rhes","negative.

rhesus",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9908749403739174,"negative
",neg,neg,negative.,neg,negative,neg,0.3858678079482934,0.9162873576447136, negative,"negative 
",neg,neg,0.8386611102591494,0.7258010313626188,positive.,negative,pos,neg,negative,neg,0.29118611010265116,0.8624985206065405,0.9704056974160127,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
13,CD000021,International 1966,STD-International-1966 0.045 0.212 3389 1476,-3.73425004005463,0.4213003511728,4865,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1969.0,Immunisation after 6 months,"Anti-D prophylaxis postpartum (overall, irrespective of ABO status)",-8.86362907047043,positive,positive,negative,negative.,positive,"positive.

immunisation",pos,negative,pos,neg,neg,pos,pos,neg,pos,"negative
",negative,0.9896730964395466,"negative
",neg,neg,positive.,pos,neutral,neu,0.3858907391447215,0.4611664794735222, positive,"positive 
",pos,pos,0.9837096911795804,0.7051251413052414,positive.,positive,pos,pos,neutral,neu,0.5409400826514958,0.5545836866036595,0.9734774464661613,pos,neg,neg,pos,pos,neu,pos,neg,neg,pos,pos,pos,pos,pos,neu,neg
14,CD000022,Abele-Horn 1997,STD-Abele_x002d_Horn-1997 1.17 0.593 58 30,0.157185583522413,0.593452345731122,88,Lungs,efficacy,DICH,1,1,no,1997.0,Overall mortality,Topical plus systemic versus no prophylaxis,0.264866395175779,negative,negative,negative,negative.,"negative, as a","negative.

overall mortality",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9950172905871582,"negative
",neg,neg,negative.,neg,negative,neg,0.5862659921517395,0.5685565325728189, negative,"negative 
",neg,neg,0.6859986817753692,0.8243014887755153,the outcome ',negative,neg,neg,negative,neg,0.39010250101088517,0.8926196184096313,0.9996240361059191,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
15,CD000023,Brink 1951,STD-Brink-1951 0.659 0.087 277 198,-0.90917743967985,0.192294479578258,475,Lungs,efficacy,DICH,1,1,no,1951.0,Symptom of sore throat on day 3,Antibiotics versus placebo for the treatment of sore throats: symptom of sore throat,-4.72804753248178,negative,neutral,negative,negative.,"negative, because it","negative.

a reduction",neg,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9993007651786864,"negative
",neg,neg,negative.,neg,neutral,neu,0.4193702280114322,0.5705295881205689, neutral,"negative 
",neu,neg,0.8818325927911468,0.2831720458509442,the outcome ',positive,neg,pos,negative,neg,0.36266394303229177,0.8157382927548791,0.8886453806027595,neu,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
16,CD000024,ARGIS-1 2004,STD-ARGIS_x002d_1-2004 1.277 0.366 83 46,0.246674048724404,0.368612074642891,129,Neurology,efficacy,DICH,1,1,no,2004.0,Dead or dependent at end of follow up (if > 1 month),Anticoagulant versus control in acute presumed ischaemic stroke,0.669196875776195,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99253902588788,"negative
",neg,neg,negative.,neg,negative.,neg,0.614420051783316,0.9353002653698466, negative,"negative 
",neg,neg,0.9783584774965433,0.5843619076727564,the outcome ',negative,neg,neg,negative,neg,0.3325446982528609,0.993775728092192,0.9988061155602024,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
17,CD000025,Denmark 2000,STD-Denmark-2000 0.934 0.216 14 17,-0.262364264467491,0.822753351207442,31,Pregnancy & Childbirth,efficacy,DICH,1,9,no,2000.0,Other antihypertensive therapy,Magnesium chloride versus methyl dopa,-0.318885683154562,neutral,neutral,neutral,negative.,neutral,neutral,neu,negative,neu,neu,neg,neu,neu,neg,neu,"negative
",negative,0.8855280758948962,"negative
",neg,neg,positive.,pos,neutral,neu,0.3843843462801042,0.7748305032128026, neutral,"neutral 
",neu,neu,0.5467072990784849,0.8460199002824107,neutral. the,neutral,neu,neu,neutral,neu,0.5617403598638363,0.7432022136477066,0.9942251886594714,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
18,CD000026,Benhamou 1991a,STD-Benhamou-1991a 0.984 0.684 63 62,-0.0170944333593002,0.730883391419396,125,Oncology,efficacy,DICH,1,1,no,1991.0,Death,Antifungals versus placebo or no treatment,-0.0233887287082859,negative,negative,negative,negative.,"negative

while","negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997901359245466,"negative
",neg,neg,negative.,neg,negative.,neg,0.7636828558308308,0.8107988085179245, negative,"negative 
",neg,neg,0.970606792359696,0.6084495301213559,negative.,negative,neg,neg,negative,neg,0.2906243861854858,0.9800482114423548,0.9996332083793187,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
19,CD000027,Read 1977,STD-Read-1977 0.045 0.72 15 15,-4.51085950651685,1.28388147753274,30,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1977.0,Failure to obtain relief,Antihistamines versus aspirin for itching in late pregnancy,-3.5134547740228,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9971221437902256,"negative
",neg,neg,negative.,neg,negative,neg,0.6959636537500882,0.911152657055614, negative,"negative 
",neg,neg,0.9603516187020577,0.6292725596308008,negative.,negative,neg,neg,negative,neg,0.7544875771271476,0.9588308677930752,0.9873908449982082,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
20,CD000028,Carter 1970,STD-Carter-1970 0.919 0.412 22 26,-0.1261512853269,0.616001988671047,48,Heart & Hypertension,efficacy,DICH,1,1,no,1970.0,Total mortality,Antihypertensive drug therapy vs control in adults 60 years or older,-0.204790386471084,negative,negative,negative,negative.,negative,"negative.

total mortality",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9834709932292612,"negative
",neg,neg,negative.,neg,negative.,neg,0.6235763616445881,0.850657374812301, negative,"negative 
",neg,neg,0.8666837790352447,0.5306579606994419,positive.,negative,pos,neg,negative,neg,0.3424997581826091,0.8605059669677273,0.9997043291858109,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
21,CD000029,CAST 1997,STD-CAST-1997 0.95 0.03 10554 10552,-0.0508720416143071,0.0299284077992531,21106,Neurology,efficacy,DICH,1,1,no,1997.0,Death or dependence at end of follow-up,Antiplatelet drug versus control in acute presumed ischaemic stroke,-1.6997911133641,negative,negative,negative,negative.,negative. death or,"negative.

death or",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9947794990275388,"negative
",neg,neg,negative.,neg,negative.,neg,0.6032952882126953,0.9103579482429508, negative,"negative 
",neg,neg,0.9552431346702552,0.5502491216800769,the outcome ',negative,neg,neg,negative,neg,0.4523478895238161,0.9929695793894742,0.9965722443734866,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
22,CD000031,Ahluwalia 2002,STD-Ahluwalia-2002 1.947 0.27 300 300,0.732679570633765,0.294990857831945,600,Psychiatry & Mental Health,efficacy,DICH,1,1,yes,2002.0,Bupropion versus placebo/control. Subgroups by length of follow-up,Bupropion. Abstinence at 6m or greater follow-up,2.48373653345952,neutral,neutral,positive,positive.,neutral. this,neutral,neu,negative,neu,pos,pos,neu,neu,neg,neu,"positive
",Positive,0.7143756746796872,"positive
",pos,pos,positive.,pos,neutral,neu,0.4318564595819113,0.5641279891864448, neutral,"positive 
",neu,pos,0.9941851261689536,0.6553959904015929,neutral. the,positive,neu,pos,neutral,neu,0.4134338773032809,0.5188898383396645,0.984894564229574,neu,pos,pos,neu,pos,neu,pos,neu,neu,neu,pos,neu,neg,pos,neu,neg
23,CD000032,Ceesay 1997,STD-Ceesay-1997 0.418 0.429 652 545,-0.889857474806,0.436970427145016,1197,Pregnancy & Childbirth,efficacy,DICH,1,2,yes,1997.0,Stillbirth,Balanced protein/energy supplementation versus control or no intervention in pregnancy,-2.03642493754088,negative,negative,negative,negative.,negative,"negative.

stillbirth",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99883054904136,"negative
",neg,neg,negative.,neg,negative.,neg,0.5914795755141447,0.8528572063435987, negative,"negative 
",neg,neg,0.9840411078331724,0.5959296810783988,the outcome ',negative,neg,neg,negative,neg,0.39655698836607406,0.9814110498886479,0.9997876141585559,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
24,CD000033,Bohn 1989,STD-Bohn-1989 1 0.365 41 41,0.0,0.498482545817653,82,Emergency & Trauma,efficacy,DICH,1,1,yes,1989.0,Death at the end of follow-up,Barbiturate vs no barbiturate,0.0,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.998012340516628,"negative
",neg,neg,negative.,neg,negative.,neg,0.7636325361840771,0.8491919870083338, negative,"negative 
",neg,neg,0.993698973964972,0.748109028538201,negative.,negative,neg,neg,negative,neg,0.4157876098657634,0.9238943776186446,0.9999487426325072,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
25,CD000034,Laurin 1987,STD-Laurin-1987 0.43 0.551 49 58,-0.968115799738741,0.620006378092995,107,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Operative delivery for fetal distress,Bed rest in hospital versus ambulatory management,-1.56146103321784,negative,negative,negative,negative.,negative,"positive.

operative",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.9973266713243804,"negative
",neg,neg,negative.,neg,negative,neg,0.5924616756798464,0.9651253505355908, negative,"negative 
",neg,neg,0.9456710329686948,0.773239869717209,the outcome ',negative,neg,neg,negative,neg,0.3619280882406086,0.9900827758825822,0.9940230223204461,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg,neg,neg,neg,neg,neg,neg
26,CD000035,Kulier 1997,STD-Kulier-1997 0.427 0.366 13 10,-2.66722820658196,1.19837853414984,23,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1997.0,No improvement in fetal heart rate abnormality,Tocolytics versus no treatment,-2.22569758267087,negative,negative,negative,negative.,negative,"negative.

a lack",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9959925045281528,"negative
",neg,neg,negative.,neg,negative,neg,0.5764784900722503,0.7948661448484252, negative,"negative 
",neg,neg,0.9796650154674672,0.588540225772128,negative.,negative,neg,neg,negative,neg,0.47301749952776984,0.9411637994347253,0.9935196139767736,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
27,CD000036,Cabero 1988,STD-Cabero-1988 1.171 0.228 44 54,0.283721671235684,0.409636245885491,98,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1988.0,Low birthweight for gestational age,Ritodrine versus control,0.692618570952814,negative,negative,negative,negative.,negative,"negative.

low birth",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998260067985733,"negative
",neg,neg,negative.,neg,negative.,neg,0.5894367389940252,0.9478359649375824, negative,"negative 
",neg,neg,0.989001981971122,0.546168326927415,negative. low,negative,neg,neg,negative,neg,0.4638067221305458,0.9865482584760362,0.9990484241334887,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
28,CD000037,Campbell 1978,STD-Campbell-1978 1.833 0.298 50 50,0.911517453121497,0.436827144275454,100,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1978.0,Forceps delivery,Prophylactic tocolytics in 2nd stage of labour,2.08667768261835,negative,negative,negative,negative.,negative,"negative.

forceps",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9759438402031886,"negative
",neg,neg,negative.,neg,negative,neg,0.4876451132676414,0.4620066346459588, negative,"negative 
",neg,neg,0.9478163682892748,0.5992914153482669,the outcome ',positive,neg,pos,negative,neg,0.4019668264616803,0.7945836580580116,0.7129793713897139,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg
29,CD000038,Alfirevic 1995,STD-Alfirevic-1995 3.041 1.625 72 73,1.12620024518694,1.64141954503702,145,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1995.0,Perinatal deaths including major malformations,Biophysical profile versus conventional fetal monitoring (CTG),0.686113582960617,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.6531340418133769,"negative
",neg,neg,negative.,neg,negative.,neg,0.5833504650140863,0.905761232807196, negative,"negative 
",neg,neg,0.95250362510398,0.8190448276658105,negative.,negative,neg,neg,negative,neg,0.41325887810931494,0.9016921518066948,0.9997099287521741,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
30,CD000039,Bath 2000,STD-Bath-2000 2 0.707 16 18,0.693147180559945,0.707106781186547,34,Neurology,efficacy,DICH,1,1,no,2000.0,"Death or dependency, end of trial by intervention",Blood pressure lowering therapy in acute stroke,0.980258143468547,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.989182987226758,"negative
",neg,neg,negative.,neg,negative.,neg,0.5861572210227232,0.923857544479382, negative,"negative 
",neg,neg,0.9840864754669152,0.6967979134804217,the outcome ',negative,neg,neg,negative,neg,0.4482564128644342,0.990577092389257,0.9400844918145786,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
31,CD000040,USA 1989,STD-USA-1989 2.981 0.523 36 36,1.15745278869104,0.562923722082412,72,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Preterm labour.,Routine transfusion versus selective transfusion.,2.05614498605477,negative,negative,negative,negative.,negative,"negative.

preterm",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9988486276383728,"negative
",neg,neg,negative.,neg,negative.,neg,0.5209422644015901,0.9006955309412126, negative,"negative 
",neg,neg,0.9576028881761368,0.5059727891598638,the outcome ',negative,neg,neg,negative,neg,0.39688274041842897,0.9817201235892206,0.9979086833450296,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
32,CD000044,Harrison 1979,STD-Harrison-1979 0.838 0.814 16 14,-0.182321556793955,0.82663978450915,30,Gynaecology & Urology,efficacy,DICH,1,1,no,1979.0,Pregnancy per patient,Bromocriptine vs Placebo,-0.220557442565162,positive,negative,positive,positive,positive,"positive.

pregnancy is",pos,negative,neg,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9994552788144838,"positive
",pos,pos,positive.,pos,negative,neg,0.467321298001676,0.4205753335390135," positive
","positive 
",pos,pos,0.510310340517711,0.7829995059153404,the outcome ',positive,neg,pos,negative,neg,0.36254208993177217,0.3347900591576385,0.5435845782389704,neg,pos,pos,pos,pos,neg,pos,pos,pos,pos,pos,pos,neg,pos,neg,neg
33,CD000046,Ingelman 1953,STD-Ingelman-1953 1.79 0.612 25 20,0.606135803570315,0.632797677328939,45,Pregnancy & Childbirth,efficacy,DICH,1,6,no,1953.0,Single injection given before symptoms subsided,Oxytocin versus placebo,0.957866669373433,neutral,positive,positive,neutral.,positive,"positive.

the outcome",neu,negative,pos,pos,neu,pos,pos,neg,neu,"negative
",negative,0.5909192876633463,"negative
",neg,neg,positive.,pos,positive,pos,0.4096597757876509,0.4947078645527589, neutral,"positive 
",neu,pos,0.4540989491452172,0.8556515068422449,positive. the,positive,pos,pos,neutral,neu,0.3672827568674136,0.8688403020183697,0.9677527943153084,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neu,neg
34,CD000047,Rabinovici 1987,STD-Rabinovici-1987 3.667 0.592 27 27,1.70474809223843,0.72691752689634,54,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Maternal febrile morbidity,Effect of caesarean delivery of the second twin,2.34517401102853,negative,negative,negative,negative.,negative,"negative.

maternal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9907326292449424,"negative
",neg,neg,negative.,neg,negative.,neg,0.5642265516401543,0.929585559173252, negative,"negative 
",neg,neg,0.9850244395244314,0.5752460506265783,negative.,negative,neg,neg,negative,neg,0.43502247375205855,0.9673397743901467,0.998442456960449,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
35,CD000048,LeBard 1989,STD-LeBard-1989 0.341 1.045 11 15,-1.29098418131557,1.20037872811421,26,Neonatal,efficacy,DICH,1,1,no,1989.0,Postoperative apnoea/bradycardia,Caffeine vs placebo with induction of general anesthesia,-1.07548072210818,negative,negative,negative,negative.,negative,"negative.

apno",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9957350617912742,"negative
",neg,neg,negative.,neg,negative,neg,0.4979590511209597,0.9404372392162184, negative,"negative 
",neg,neg,0.975571543437826,0.6462753828597472,negative. post,negative,neg,neg,negative,neg,0.3223309715946915,0.9718517099810597,0.9993306113585311,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
36,CD000049,Janssens 1985,STD-Janssens-1985 0.496 0.53 50 50,-0.72676379135893,0.553122098585887,100,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1985.0,Preterm birth (< 38 weeks),Flunarizine versus no treatment,-1.31393013082821,negative,negative,negative,negative.,negative,"negative.

preterm",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997545908777462,"negative
",neg,neg,negative.,neg,negative,neg,0.4571433615171861,0.8349708337455383, negative,"negative 
",neg,neg,0.949649470630728,0.6144997836791815,positive. pre,negative,pos,neg,negative,neg,0.2727483617181212,0.9626327502485348,0.9997890440762561,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
37,CD000050,Ford-London,STD-Ford_x002d_London 0.127 0.847 35 38,-2.65324196460721,1.48754307456957,73,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1995.0,Number lost to follow up,CASE MANAGEMENT vs STANDARD CARE,-1.78364042693348,negative,neutral,negative,negative.,"negative, as it implies","negative.

loss to",neu,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9887492108792102,"negative
",neg,neg,negative.,neg,negative.,neg,0.4933223324592468,0.8147991325956331, negative,"negative 
",neg,neg,0.9950821261950972,0.599065025541149,the outcome ',negative,neg,neg,negative,neg,0.3077056862567304,0.9763763828703784,0.9103666369170489,neu,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
38,CD000051,Bung 1987,STD-Bung-1987 0.664 0.342 30 31,-0.653141845946246,0.537570701927193,61,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Non-cephalic births,Cephalic version by postural management,-1.21498780272945,negative,negative,negative,negative.,negative,"negative.

cephal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9986955774995872,"negative
",neg,neg,negative.,neg,negative,neg,0.4131924259156538,0.5390446158001405, negative,"positive 
",neg,pos,0.9875585822475484,0.8561673696647937,neutral. the,negative,neu,neg,negative,neg,0.5329987704276948,0.9344057529594231,0.9862202518682119,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neu,neg,neg,neg
39,CD000052,Chou 1995,STD-Chou-1995 0.913 0.651 71 81,-0.0971028304188448,0.691435657072421,152,Lungs,efficacy,DICH,1,1,no,1995.0,Hospital admission,Spacer (chamber) versus nebuliser (multiple-treatment studies),-0.140436538708437,negative,negative,negative,negative.,negative,"negative.

hospital admission",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9992083938356088,"negative
",neg,neg,negative.,neg,negative.,neg,0.4995870498764899,0.8878332387651983, negative,"negative 
",neg,neg,0.975530246089271,0.6735502853826111,positive.,negative,pos,neg,negative,neg,0.3962381401828319,0.9512611502232948,0.9996963469717116,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
40,CD000053,Abden Abdi 1989 SOM,STD-Abden-Abdi-1989-SOM 0.915 0.141 100 101,-0.179133610317767,0.282427619799725,201,Infectious Diseases,efficacy,DICH,1,9,yes,1989.0,Parasitological failure,Metrifonate 3 doses 2 weeks apart: 7.5 mg/kg versus 5 mg/kg,-0.634263782149901,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9972845694692384,"negative
",neg,neg,negative.,neg,negative,neg,0.4799817295021917,0.6248034998032033, negative,"negative 
",neg,neg,0.99287109157665,0.6887467200343004,the outcome ',negative,neg,neg,negative,neg,0.3571444613595446,0.9796719952310365,0.9903871637471072,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
41,CD000054,Martin 1997,STD-Martin-1997 7.426 2 202 203,1.10848891216402,1.63601450199471,405,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1997.0,Neonatal death,Antibiotic therapy versus placebo or no therapy,0.677554453712052,negative,negative,negative,negative.,negative,"negative.

neonatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9987356485666372,"negative
",neg,neg,negative.,neg,negative.,neg,0.7536742212861612,0.8276584461534359, negative,"negative 
",neg,neg,0.9495506814018606,0.5988209104294173,negative.,negative,neg,neg,negative,neg,0.5031037592048043,0.9194119532029633,0.9999349159632668,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
42,CD000055,Canadian Trial,STD-Canadian-Trial 0.363 0.089 1391 1396,-1.05758548217283,0.0953946120934783,2787,Pregnancy & Childbirth,efficacy,DICH,1,1,no,,Not complied with allocated procedure,Chorion villus sampling vs amniocentesis,-11.0864278281932,neutral,neutral,negative,negative.,"negative, because it","negative.

the outcome",neu,negative,neu,neg,neg,neg,neg,neg,neu,"negative
",negative,0.5038927153193015,"negative
",neg,neg,negative.,neg,negative,neg,0.658801929938268,0.8340264454316747, negative,"negative 
",neg,neg,0.914800791274229,0.514440817792089,neutral. the,negative,neu,neg,negative,neg,0.42070711286706614,0.9547417160375314,0.8937824829482801,neu,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neu,neg,neg,neg
43,CD000056,Connaughton 1974,STD-Connaughton-1974 1.292 0.506 31 31,0.260883879297057,0.511512755603708,62,Gynaecology & Urology,efficacy,DICH,1,1,no,1974.0,Ovulation following all dose ranges,Clomiphene citrate in oligo-amenorrheic women vs placebo,0.510024190871156,positive,positive,positive,positive,positive,"positive.

ovulation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9981324634206146,"positive
",pos,pos,positive.,pos,positive,pos,0.5261927450112935,0.8312693206364412, positive,"positive 
",pos,pos,0.9966231561692924,0.8329611055035357,positive.,positive,pos,pos,positive,pos,0.5937331929773131,0.5021924612051691,0.9983305238490786,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
44,CD000057,Battacharya 2008,STD-Battacharya-2008 0.789 0.285 192 193,-0.238222788150325,0.28626354111431,385,Gynaecology & Urology,efficacy,DICH,1,1,yes,2008.0,Live birth per woman randomised,Clomiphene versus placebo or no treatment in unexplained subfertility,-0.832179980807261,positive,positive,positive,positive,positive,"positive.

live birth",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9997305369916796,"positive
",pos,pos,positive.,pos,positive,pos,0.5780201175349657,0.5898841539360133, positive,"positive 
",pos,pos,0.9283985238477086,0.8477043901740333,positive.,positive,pos,pos,positive,pos,0.5437911685428185,0.9831150397655921,0.999652983018083,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
45,CD000058,Glassman 1988,STD-Glassman-1988 5.182 0.745 33 38,1.90954250488444,0.824957911384305,71,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1988.0,Smoking Cessation,Clonidine vs placebo,2.31471506428754,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9991764929681884,"positive
",pos,pos,positive.,pos,positive,pos,0.6079600216924397,0.5461511711497389, positive,"positive 
",pos,pos,0.9603523878839078,0.8371455799380835,positive. s,positive,pos,pos,positive,pos,0.4458451680544384,0.7653378527453386,0.9899756297038118,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
46,CD000059,Essock 1996 (H/CPZ/Flu),STD-Essock-1996-_x0028_H_x002f_CPZ_x002f_Flu_x0029_ 0.645 0.805 138 89,-0.450927482184922,0.828071241531076,227,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1996.0,Death,CLOZAPINE versus TYPICAL ANTIPSYCHOTICS - OVERALL,-0.544551554949755,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997387536307772,"negative
",neg,neg,negative.,neg,negative.,neg,0.8796695528445299,0.7466883793975253, negative,"negative 
",neg,neg,0.997146427870322,0.7100662281814195,the outcome ',negative,neg,neg,negative,neg,0.3848448828833862,0.9927984719208872,0.9997971469430569,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
47,CD000060,Benito Fernandez 2000,STD-Benito-Fernandez-2000 0.667 0.231 51 51,-0.723918839226699,0.405662778132638,102,Lungs,efficacy,DICH,1,1,no,2000.0,Primary outcome: hospital admissions,Anticholinergic and beta2-agonists versus beta2-agonists alone (all protocols),-1.78453355409897,negative,negative,negative,negative.,negative,"negative.

hospital admissions",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9982178535123036,"negative
",neg,neg,negative.,neg,negative.,neg,0.4067218839281881,0.6307074322173838, neutral,"negative 
",neu,neg,0.8459364607896422,0.8300866955685383,the primary outcome,negative,neg,neg,negative,neg,0.4235287673342648,0.8066474225420832,0.9997581828433341,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg,neg
48,CD000061,Daya 1995a,STD-Daya-1995a 1.723 0.362 115 117,0.554114618819437,0.37060024678788,232,Gynaecology & Urology,efficacy,DICH,1,1,no,1995.0,pregnancy per cycle start,FSH vs hMG in IVF: clinical pregnancy,1.49518146202583,positive,positive,positive,positive,positive,"positive.

pregnancy per",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9914884203612162,"positive
",pos,pos,negative.,neg,positive,pos,0.4108079357897709,0.7331549622292531, positive,"positive 
",pos,pos,0.9859345264816638,0.8308411051093519,positive.,positive,pos,pos,positive,pos,0.3859328790583742,0.9268589192055696,0.9998446944204133,pos,pos,pos,pos,neg,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
49,CD000062,Flint 1989,STD-Flint-1989 0.139 0.162 503 498,-2.60217206795214,0.257972984299229,1001,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Antenatal clinic waiting time > 15 min,Continuity of caregivers during pregnancy and childbirth,-10.0869944774288,negative,negative,negative,negative.,negative,"negative.

a longer",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9923041458995252,"negative
",neg,neg,negative.,neg,negative.,neg,0.4052658727823952,0.9077667398080036, negative,"negative 
",neg,neg,0.9850028107997972,0.6103627566077097,negative.,negative,neg,neg,negative,neg,0.41749144428706414,0.9842679889189732,0.8947159504025689,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
50,CD000063,Athens 1993,STD-Athens-1993 1.1 0.168 746 682,0.104976261050519,0.184716749383225,1428,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1993.0,Cesarean delivery,Continuous electronic fetal heart rate monitoring versus intermittent auscultation,0.568309378554126,negative,negative,negative,negative.,negative,"negative.

cesarean",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99861152312721,"neutral
",neg,neu,negative.,neg,negative,neg,0.4397905576395054,0.8584907041085917, negative,"negative 
",neg,neg,0.8857507628800763,0.8093484737010451,the outcome ',negative,neg,neg,negative,neg,0.36682436703500654,0.8072699852763284,0.9805989223707685,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg,neg,neg,neg,neg
51,CD000064,Bauer 1973,STD-Bauer-1973 0.425 0.616 28 26,-0.890067536775052,0.64297192893037,54,Neurology,efficacy,DICH,1,1,yes,1973.0,All deaths,Corticosteroids versus placebo,-1.38430232600627,negative,negative,negative,negative.,negative,"negative.

all deaths",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9992904089788696,"negative
",neg,neg,negative.,neg,negative,neg,0.7392459347021498,0.7513068710057068, negative,"negative 
",neg,neg,0.9908600142349614,0.8783525859615742,neutral. the,negative,neu,neg,negative,neg,0.27825641441037285,0.9754884998755352,0.9990132065753192,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg
52,CD000065,AMSTERDAM 1980,STD-AMSTERDAM-1980 0.507 0.429 64 58,-0.69203791810566,0.439307169019123,122,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1979.0,RDS,Corticosteroids versus placebo or no treatment,-1.57529393306016,negative,negative,negative,negative.,"negative

i am","negative.

rds (",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9984511856528266,"negative
",neg,neg,negative. r,neg,neutral,neu,0.5530715664563878,0.4621440684125106, negative,"negative 
",neg,neg,0.8423440609250329,0.6358193447964916,the outcome ',negative.,neg,neg,negative,neg,0.36009939828655935,0.9729026586139758,0.9997008741919668,neg,neg,neg,neg,neg,neu,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
53,CD000066,Buchanan 2010,STD-Buchanan-2010 0.801 0.13 122 123,-0.442698178555468,0.257122736074076,245,Pregnancy & Childbirth,efficacy,DICH,1,2,yes,2010.0,Presence of stretch marks,Topical preparations with active ingredients compared with other topical preparations with active ingredient,-1.72173875136397,negative,negative,negative,negative.,negative,"negative.

stretch marks",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9996993356086,"negative
",neg,neg,positive.,pos,negative,neg,0.4612057335285266,0.5682216423283999, negative,"negative 
",neg,neg,0.9170867369829834,0.5534363525495215,the outcome ',negative,neg,neg,negative,neg,0.3429402611403648,0.989287271415312,0.9052560837479733,neg,neg,neg,neg,pos,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
54,CD000067,Candy 1995,STD-Candy-1995 5.542 0.691 24 19,2.47653840011748,0.854547892654552,43,Gastroenterology,efficacy,DICH,1,1,no,1995.0,Maintenance of remission,Azathioprine versus placebo,2.89806858270332,positive,positive,positive,positive,positive,"positive.

maintenance of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.999885928056699,"positive
",pos,pos,positive.,pos,positive,pos,0.4782949871669716,0.5402125357677071, positive,"positive 
",pos,pos,0.985036005862605,0.9017102775037492,positive. maint,positive,pos,pos,positive,pos,0.5276344594065243,0.9266162730745198,0.979336882206631,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
55,CD000069,Iffland 1989,STD-Iffland-1989 0.161 2.009 14 17,-0.969400557188104,1.67219563583754,31,Gynaecology & Urology,efficacy,DICH,1,1,no,1989.0,Live birth/ongoing pregnancies per woman randomised following treatment,Danazol versus placebo in unexplained subfertility,-0.579717191225995,positive,positive,positive,positive,positive,"positive.

live birth",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9981614395267993,"positive
",pos,pos,positive.,pos,positive,pos,0.5744747602179153,0.7003328460805467, positive,"positive 
",pos,pos,0.9283992432272222,0.845703557013388,positive.,positive,pos,pos,positive,pos,0.5425045562554242,0.9689387997621154,0.9991952701671271,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
56,CD000070,Li 1987,STD-Li-1987 0.764 0.369 85 73,-0.270656122861854,0.36966338556474,158,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Induction or elective Caesarean,Dietary regulation for 'gestational diabetes',-0.73216913936004,negative,negative,negative,negative.,negative,"negative.

induction or",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.967899138402028,"negative
",neg,neg,negative.,neg,negative,neg,0.3996928805158756,0.8194073392019421, neutral,"negative 
",neu,neg,0.4941790347150516,0.6310451461633638,neutral. the,negative,neu,neg,negative,neg,0.42308346526760277,0.9353518896648167,0.9466096888187023,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neu,neg,neg,neg
57,CD000071,AbuRahma 1996,STD-AbuRahma-1996 2.954 1.161 134 130,1.08322736982863,1.16134355773995,264,Neurology,efficacy,DICH,1,1,no,1996.0,Ipsilateral stroke,Perioperative events: synthetic versus vein (< 30 days),0.932736366090202,negative,negative,negative,negative.,negative,"negative.

an ips",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99736806702481,"negative
",neg,neg,negative.,neg,negative.,neg,0.6451336281806789,0.9379906560138608, negative,"negative 
",neg,neg,0.9914170867882676,0.7136773628922862,the outcome ',negative,neg,neg,negative,neg,0.3685091401755713,0.8881972239852051,0.999629634757054,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
58,CD000073,Chester 1992,STD-Chester-1992 0.297 0.897 338 336,-1.40124232255576,1.12070487071451,674,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1992.0,Perinatal deaths,Doppler ultrasound in high risk pregnancies,-1.25032232764582,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9924224529710356,"negative
",neg,neg,negative.,neg,negative.,neg,0.6211897897284009,0.8306228532337051, negative,"negative 
",neg,neg,0.9601449672252044,0.6964896659685197,positive.,negative,pos,neg,negative,neg,0.33636356863781813,0.714965568540308,0.9998288447627128,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
59,CD000074,Peliowski 1990,STD-Peliowski-1990 0.455 0.429 11 10,-1.94591014905531,1.00888906370182,21,Neonatal,efficacy,DICH,1,1,no,1990.0,Failed treatment in first 48 hours,Doxapram vs placebo,-1.92876523204183,negative,negative,negative,negative.,negative,"negative.

failed treatment",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9995268389360196,"negative
",neg,neg,negative.,neg,negative,neg,0.684034282682014,0.9238824691547162, negative,"negative 
",neg,neg,0.9859316294920976,0.6718617064949028,negative.,negative,neg,neg,negative,neg,0.581122505708237,0.9860009300198774,0.9978366310469018,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
60,CD000075,Eyal 1985,STD-Eyal-1985 1.556 1.116 9 7,0.538996500732687,1.3451854182691,16,Neonatal,efficacy,DICH,1,1,no,1985.0,Failed treatment in the first 48 hrs,Doxapram vs aminophylline,0.400685655235718,negative,negative,negative,negative.,negative,"negative.

failed treatment",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9953175659360954,"negative
",neg,neg,negative.,neg,negative,neg,0.669957436031897,0.9520112375380848, negative,"negative 
",neg,neg,0.9867656187011647,0.7768012072034575,negative. the,negative,neg,neg,negative,neg,0.484965301833109,0.9901107053526877,0.9990688895232404,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
61,CD000076,Abraham 1987,STD-Abraham-1987 0.333 0.549 14 14,-1.88706964903238,0.857527571191466,28,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1987.0,Global impression: 1a. Not improved,ECT versus PLACEBO or SHAM ECT,-2.2005935580712,negative,negative,negative,negative.,negative,"negative.

a global",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998727028729668,"negative
",neg,neg,negative.,neg,negative,neg,0.4730923042302943,0.8289549511050543, negative,"negative 
",neg,neg,0.999029982182954,0.5074662277254123,negative.,negative,neg,neg,negative,neg,0.4690646134690628,0.9771431707926891,0.9960745303195168,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
62,CD000077,Copenhagen Trial,STD-Copenhagen-Trial 1.37 0.262 581 579,0.331146557916953,0.274947842853416,1160,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1997.0,Not complied with allocated procedure,Early amniocentesis vs chorion villus sampling,1.20439773042154,neutral,neutral,negative,negative.,negative,"negative.

the outcome",neu,negative,neu,neg,neg,neg,neg,neg,neu,"neutral
",Neutral,0.6315789343442781,"negative
",neu,neg,negative.,neg,negative,neg,0.6790952880312551,0.9059965007247116, negative,"negative 
",neg,neg,0.946527125386136,0.5661194187495189,neutral. the,negative,neu,neg,negative,neg,0.46041900910740113,0.9736847911277031,0.921236072259249,neu,neg,neg,neg,neg,neg,neg,neu,neg,neu,neg,neg,neu,neg,neg,neg
63,CD000078,Zlatnik 1993,STD-Zlatnik-1993 0.556 1.181 18 20,-0.635988766719997,1.27058218347627,38,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1993.0,Birth injury to infant,Planned immediate caesarean section versus planned vaginal delivery in singletons (infant outcomes),-0.5005490986659,negative,negative,negative,negative.,negative,"negative.

birth injury",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9722565004330018,"negative
",neg,neg,negative.,neg,negative.,neg,0.6737210108927643,0.9253112438800808, negative,"negative 
",neg,neg,0.9578944099051554,0.6895576350361127,the outcome ',negative,neg,neg,negative,neg,0.39073008634786716,0.8316388413834763,0.9993272780068878,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
64,CD000080,Campbell 1975,STD-Campbell-1975 0.629 0.556 51 51,-0.474457979595116,0.569042637953892,102,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1975.0,Pre-eclampsia,Energy/protein restriction in pregnant women with high weight-for-height or weight gain,-0.833782827418919,negative,negative,negative,negative.,negative,"negative.

pre-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99974685094763,"negative
",neg,neg,negative.,neg,negative.,neg,0.5979596277396542,0.8681052647778804, negative,"negative 
",neg,neg,0.9953819192402024,0.7404504157477974,the outcome ',negative,neg,neg,negative,neg,0.33114111608095476,0.9427187056953715,0.9996868161084356,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
65,CD000081,Belizan 1993,STD-Belizan-1993 0.796 0.343 1298 1308,-0.231723139740679,0.347639848163177,2606,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1993.0,Severe perineal/vaginal trauma,Restrictive versus routine episiotomy (where non-instrumental was intended),-0.666560927825257,negative,negative,negative,negative.,negative,"negative.

severe perine",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.999343618712508,"negative
",neg,neg,negative.,neg,negative.,neg,0.6952740559141863,0.893919826148755, negative,"negative 
",neg,neg,0.978373654017404,0.653751774499692,negative. se,negative,neg,neg,negative,neg,0.46061156278757404,0.9522945010702648,0.9996719244964946,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
66,CD000083,Brocks 1984,STD-Brocks-1984 0.643 0.178 31 34,-1.56370190311142,0.603932826944376,65,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1984.0,Vaginal cephalic birth not achieved (CS + breech vaginal birth) (not prespecified),External cephalic version at term versus no ECV attempt,-2.5891983898657,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9477693670764687,"negative
",neg,neg,negative.,neg,negative,neg,0.5228820880354378,0.8038128737763812, negative,"negative 
",neg,neg,0.7964817537458739,0.7945473804546449,neutral. the,negative,neu,neg,negative,neg,0.44296821358671573,0.9448541614547399,0.9290402242785587,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg
67,CD000084,Akhtar 2013,STD-Akhtar-2013 0.676 0.213 63 60,-0.689220987844664,0.369574907824927,123,Pregnancy & Childbirth,efficacy,DICH,1,3,yes,2013.0,Non-cephalic presentation at the birth,External cephalic version (ECV) commenced before term versus ECV at term,-1.86490200836675,negative,negative,negative,negative.,negative,"negative.

non-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9879476603418632,"negative
",neg,neg,positive.,pos,negative.,neg,0.4078031286293025,0.91554032456554, negative,"negative 
",neg,neg,0.9668999082817246,0.5540731440876401,neutral. the,negative,neu,neg,negative,neg,0.37948120388538364,0.9793269351285186,0.9782779263308787,neg,neg,neg,neg,pos,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg
68,CD000087,Gadir 1990,STD-Gadir-1990 0.535 0.523 29 30,-0.641853886172395,0.534756872121062,59,Gynaecology & Urology,efficacy,DICH,1,1,no,1990.0,Pregnancy per patient,Daily FSH vs HMG for PCOD Patients,-1.20027234736889,positive,positive,positive,positive,positive,"positive.

pregnancy is",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.999876632920344,"positive
",pos,pos,negative.,neg,positive,pos,0.4309958558659699,0.6501137413380301, positive,"positive 
",pos,pos,0.9840925940529544,0.9650156547763789,positive.,positive,pos,pos,positive,pos,0.49695845379893133,0.5641113788546778,0.9941079552744218,pos,pos,pos,pos,neg,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
69,CD000088,Bloch 1995,STD-Bloch-1995 1.744 0.498 32 31,0.710388986994452,0.62693772453268,63,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1995.0,Service utilisation: 1. Hospital admission,ANY FAMILY-BASED INTERVENTIONS (> 5 sessions) vs STANDARD CARE,1.13310933318613,negative,negative,negative,negative.,"negative, as hospital admission","negative.

reduced hospital",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9825572590554768,"negative
",neg,neg,negative.,neg,negative.,neg,0.5179427838879304,0.8476750975828808, negative,"negative 
",neg,neg,0.9554515963883916,0.7602082133194781,the outcome ',negative,neg,neg,negative,neg,0.5520662711525309,0.95437555389598,0.4978255356786728,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
70,CD000089,Gustafsson 1986,STD-Gustafsson-1986 0.122 0.958 9 8,-2.63905732961526,1.28173988892331,17,Lungs,efficacy,DICH,1,1,no,1986.0,General paediatric assessment - no improvement,FAMILY THERAPY & DRUG THERAPY vs DRUG THERAPY ALONE,-2.05896481214463,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991441162775964,"negative
",neg,neg,negative.,neg,negative.,neg,0.5074446315811701,0.806986373123426, negative,"negative 
",neg,neg,0.9947748459281436,0.6453402882585699,negative.,negative,neg,neg,negative,neg,0.5969422259933994,0.9907699012930316,0.998567609301954,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
71,CD000091,AISS 1994,STD-AISS-1994 0.749 0.157 64 68,-0.66865616055165,0.356307499518462,132,Neurology,efficacy,DICH,1,1,yes,1994.0,Death or dependency at the end of follow-up,Fibrinogen depleting agents versus control,-1.87662668188381,negative,negative,negative,negative.,negative,"negative.

death or",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991441162775964,"negative
",neg,neg,negative.,neg,negative.,neg,0.7369682475103646,0.9243370201362504, negative,"negative 
",neg,neg,0.985017961957345,0.7855605233345201,the outcome ',negative,neg,neg,negative,neg,0.5707032502713051,0.992770155971063,0.9991550438716075,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
72,CD000092,Acton 1988,STD-Acton-1988 1.695 0.199 203 217,0.53130075846847,0.201135984797292,420,Gynaecology & Urology,efficacy,DICH,1,1,no,1988.0,Pregnancy rate (overall),OIL SOLUBLE VERSUS WATER SOLUBLE CONTRAST MEDIA FOR TUBAL FLUSHING,2.6415002715895,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9995121818919622,"positive
",pos,pos,positive.,pos,neutral,neu,0.5401133714073998,0.5925986371361642, positive,"positive 
",pos,pos,0.8207289283958128,0.9285018020146456,neutral. the,positive,neu,pos,positive,pos,0.4400821752804929,0.9745770918226149,0.6306650286345932,pos,pos,pos,pos,pos,neu,pos,pos,pos,pos,pos,pos,neu,pos,pos,neg
73,CD000093,Barton 2010,STD-Barton-2010 1.196 0.15 100 110,0.330241686870577,0.278144082149491,210,Emergency & Trauma,efficacy,DICH,1,8,no,2010.0,Number of patients transfused,Long Gamma nail versus sliding hip screw (SHS),1.18730437950891,negative,negative,negative,negative.,negative. a higher number,"negative.

transfusion",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9953175659360954,"negative
",neg,neg,negative.,neg,negative,neg,0.5421030943440663,0.4838158820005127," negative

","negative 
",neg,neg,0.6519310459470333,0.4889695530061613,neutral. the,negative.,neu,neg,neutral,neu,0.3734884165884831,0.6521651109736957,0.7763008781735659,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neu,neg
74,CD000094,Angeleri 1992,STD-Angeleri-1992 0.343 0.608 55 57,-1.17865499634165,0.696066481744773,112,Neurology,efficacy,DICH,1,1,no,1992.0,Case fatality at the end of scheduled follow-up,Ganglioside versus control. Intention-to-treat analysis,-1.69330807796865,negative,negative,negative,negative.,negative,"negative.

case fatality",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.979820642425998,"negative
",neg,neg,negative.,neg,negative.,neg,0.4634520890453057,0.8473338042557197, negative,"negative 
",neg,neg,0.9687661401402252,0.904627293053016,the outcome ',negative,neg,neg,negative,neg,0.29056428310654664,0.9726008011510882,0.999925142169393,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
75,CD000096,Albizzati 1979,STD-Albizzati-1979 1.481 0.493 46 47,0.398907707562005,0.500171969050657,93,Neurology,efficacy,DICH,1,1,no,1979.0,Death within the scheduled treatment period,CI and/or PICH stroke: intravenous glycerol versus avoid glycerol,0.797541110348798,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9967266155431675,"negative
",neg,neg,negative.,neg,negative.,neg,0.6398039591239854,0.9080980034078794, negative,"negative 
",neg,neg,0.9944353354195968,0.5299333454858351,the outcome ',negative,neg,neg,negative,neg,0.36761894912959014,0.9843541505970597,0.9995349425236921,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
76,CD000097,Bachus 1990,STD-Bachus-1990 1.712 0.646 33 26,0.56531380905006,0.678568010927825,59,Gynaecology & Urology,efficacy,DICH,1,1,no,1990.0,Pregnancy per cycle,GnRH-a + HMG/FSH vs HMG/FSH,0.833098230311639,positive,positive,positive,positive,positive,"positive.

pregnancy per",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9990600813005656,"positive
",pos,pos,positive.,pos,positive,pos,0.4475683876165675,0.6344862495299065, positive,"positive 
",pos,pos,0.9953899509881972,0.935818421492826,positive.,positive,pos,pos,positive,pos,0.4776848364386758,0.6602515368495885,0.9977753885233976,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
77,CD000098,Cavenee 1993,STD-Cavenee-1993 2.485 0.53 84 164,0.85015092936961,0.505820818921781,248,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1993.0,Failure to achieve microbiological cure,Any penicillin versus any other antibiotic,1.68073534652411,negative,negative,negative,negative.,negative,"negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9984022280987928,"negative
",neg,neg,negative.,neg,negative.,neg,0.6767706409464654,0.929044958862746, negative,"negative 
",neg,neg,0.9648491648124704,0.5657376066185852,negative.,negative,neg,neg,negative,neg,0.30167179110195474,0.969330113732468,0.9980040175979453,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
78,CD000099,Owen 1991,STD-Owen-1991 11.842 1.552 13 12,2.47166142303798,1.55160735371967,25,Gynaecology & Urology,efficacy,DICH,1,2,no,1991.0,Live birth rate per woman randomised,Growth hormone versus placebo: Poor responder as defined by the study,1.59296836091467,positive,positive,positive,positive,positive,neutral,pos,negative,pos,pos,pos,pos,neu,neg,pos,"positive
",positive,0.9998910553598984,"positive
",pos,pos,negative.,neg,positive,pos,0.4203119488079458,0.5152903333272767, neutral,"neutral 
",neu,neu,0.647568631392238,0.4702796641945493,the outcome ',positive,neg,pos,positive,pos,0.2831118302328628,0.985232681919494,0.9654356954161765,pos,pos,pos,pos,neg,pos,neu,pos,pos,pos,neu,neu,neg,pos,pos,neg
79,CD000100,Averhoff 1998,STD-Averhoff-1998 1.308 0.126 891 874,0.307150565345716,0.14430914627938,1765,Hepato-Biliary,efficacy,DICH,1,6,no,1998.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at follow-up (7 months),Different brands of RV (10 µg Recombinvax-HB versus 20 µg Engerix-B by intramuscular route),2.12842063905691,negative,negative,negative,negative,"negative, because a lower","negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9799745412218632,"negative
",neg,neg,negative.,neg,negative,neg,0.5938443964324936,0.6566392089027888, negative,"negative 
",neg,neg,0.9987487970412616,0.809163997298091,neutral. the,negative,neu,neg,negative,neg,0.5852637771887411,0.9772433435337686,0.9936948543137539,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg
80,CD000101,Harrison 1985,STD-Harrison-1985 0.054 0.914 10 10,-3.80666248977032,1.58564993434418,20,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1985.0,Miscarriage,HCG vs placebo for recurrent spontaneous miscarriage (RSM),-2.40069539141042,negative,negative,negative,negative.,negative,"negative.

miscarriage",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9999251418860085,"negative
",neg,neg,negative.,neg,negative,neg,0.741235826446403,0.8779549042185048, negative,"negative 
",neg,neg,0.985033808724941,0.6997887068088339,the outcome ',negative,neg,neg,negative,neg,0.43623503572198447,0.9590812530139299,0.999224311275048,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
81,CD000102,"Connor AN, IP, PNb",STD-Connor-AN_x002c_-IP_x002c_-PNb 0.305 0.357 121 127,-1.39091330697619,0.403378747236983,248,Infectious Diseases,efficacy,DICH,1,1,no,1994.0,HIV infection status in the child,Any zidovudine vs placebo/no treatment,-3.44815713892589,negative,negative,negative,negative.,"negative, because hiv infection","positive.

hiv infection",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.9976752015395272,"negative
",neg,neg,negative.,neg,negative,neg,0.5272251147981499,0.6757612333990792, negative,"positive 
",neg,pos,0.551542068912983,0.8077515398405641,positive.,positive,pos,pos,negative,neg,0.4436809799418234,0.8807854839234128,0.8696310465170216,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg,pos,neu,pos,pos,neg,neg
82,CD000103,ALIAS-Part 1 2011,STD-ALIAS_x002d_Part-1-2011 1.514 0.423 207 217,0.437404700763307,0.444967998306775,424,Neurology,efficacy,DICH,1,1,no,2011.0,Mortality at early follow-up (not later than 28 days),"Haemodilution, all types, versus control",0.983002603395642,negative,negative,negative,negative.,negative,"negative.

mortality at",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9940885279176253,"negative
",neg,neg,negative.,neg,negative.,neg,0.5598371072717868,0.8062642684226262, negative,"negative 
",neg,neg,0.9932904472229171,0.8665241435191523,positive.,negative,pos,neg,negative,neg,0.3239117524737668,0.952413217372764,0.9995575717425459,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
83,CD000104,Clark 1992,STD-Clark-1992 1.059 0.529 37 28,0.0707690708882072,0.647818444519791,65,Neonatal,efficacy,DICH,1,1,yes,1992.0,Death by 28 to 30 days,HFOV versus CV (all trials),0.109242136414727,negative,negative,negative,negative.,negative,"negative.

death within",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9951321585304722,"negative
",neg,neg,negative.,neg,negative.,neg,0.702224730884021,0.8662367394407379, negative,"negative 
",neg,neg,0.9975221907669928,0.5033569158643609,the outcome ',negative,neg,neg,negative,neg,0.2683414255385286,0.9824866996296577,0.999864954118506,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
84,CD000105,Rush 1980,STD-Rush-1980 1.694 0.249 249 256,0.534773035057438,0.253817554364473,505,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1980.0,SGA,High protein supplementation in pregnancy,2.10691902849841,negative,negative,negative,negative.,"negative

sga","negative.

sga",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.995094260639003,"negative
",neg,neg,positive.,pos,negative,neg,0.3510170300793753,0.7782286097720849, negative,"negative 
",neg,neg,0.9737223140263116,0.6328095242898655,the outcome ',negative.,neg,neg,negative,neg,0.3428892854932087,0.986967513606674,0.9989566970900982,neg,neg,neg,neg,pos,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
85,CD000106,Cameron 1993,STD-Cameron-1993 0.984 0.26 127 125,-0.0196084713883762,0.320847411235342,252,Emergency & Trauma,efficacy,DICH,1,1,no,1993.0,Dead by the end of scheduled follow-up,Organised inpatient rehabilitation vs Conventional care,-0.0611146317586877,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9968270208719808,"negative
",neg,neg,negative.,neg,negative.,neg,0.7181714366707123,0.901232097455226, negative,"negative 
",neg,neg,0.9919204778466396,0.813964786594002,negative.,negative,neg,neg,negative,neg,0.4337339076205363,0.9700801469266667,0.9999187058723578,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
86,CD000107,Brooks-Gunn 1994,STD-Brooks_x002d_Gunn-1994 1.047 0.321 345 551,0.0455014602422144,0.319747729101975,896,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1994.0,Child injury,Additional home based support vs usual support for socially disadvantaged mothers,0.142304248321035,negative,negative,negative,negative.,negative,"negative.

child injury",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991306657901246,"negative
",neg,neg,negative.,neg,negative.,neg,0.6838635320650074,0.9233319150965728, negative,"negative 
",neg,neg,0.9755308130142402,0.6033598384321793,negative.,negative,neg,neg,negative,neg,0.386486023591979,0.9676580156926863,0.9988331121506548,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
87,CD000108,Duenhoelter 1976,STD-Duenhoelter-1976 0.557 0.622 315 307,-0.595626225458455,0.631985688345929,622,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1976.0,Fetal death,Oestriol levels reported versus not reported,-0.94246790147632,negative,negative,negative,negative.,negative,"negative.

fetal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9971987223211012,"negative
",neg,neg,negative.,neg,negative.,neg,0.674091037847208,0.8144583204520647, negative,"negative 
",neg,neg,0.9932779800813308,0.6128353649708695,positive.,negative,pos,neg,negative,neg,0.33426134916635436,0.9802983435246697,0.9996035479401092,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
88,CD000110,Crowther 1989,STD-Crowther-1989 0.986 0.993 140 138,-0.0145987994211527,1.00727320920794,278,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1989.0,Perinatal death,Hospitalisation for bed rest for women with a multiple pregnancy,-0.0144933859926964,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9750102404634604,"negative
",neg,neg,negative.,neg,negative.,neg,0.6507613984896357,0.8754498801023657, negative,"negative 
",neg,neg,0.9858999954709488,0.6108915207671815,negative.,negative,neg,neg,negative,neg,0.5053944419443572,0.6587343734018346,0.9998364716001731,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
89,CD000111,Cammu 1994,STD-Cammu-1994 0.935 0.071 54 56,-0.573187865480966,0.605266035369603,110,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1994.0,Mode of birth (spontaneous vaginal birth),Immersion in water versus no immersion during first stage of labour,-0.947001536491225,positive,positive,positive,positive,positive,"positive.

spontaneous",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9995364907536158,"positive
",pos,pos,positive.,pos,positive,pos,0.4308994288161781,0.666901458877098, positive,"positive 
",pos,pos,0.880777989736479,0.9529727050317242,positive.,positive,pos,pos,positive,pos,0.4388222215927757,0.8858107200716719,0.9985629734360079,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
90,CD000112,Cauchi 1991,STD-Cauchi-1991 0.703 0.66 20 22,-0.361790044605503,0.670034988972133,42,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1991.0,Live birth rate,Paternal white cell immunization versus placebo,-0.539956943383668,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.99950444378856,"positive
",pos,pos,positive.,pos,positive,pos,0.581016974522773,0.5790580051080633, positive,"positive 
",pos,pos,0.8437029832844343,0.8516449220674049,positive.,positive,pos,pos,positive,pos,0.35189476775113765,0.8382743415833545,0.9424791226614178,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
91,CD000114,Barkai 1989,STD-Barkai-1989 2.231 0.296 84 84,1.05769316433378,0.379041106963134,168,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1989.0,Failure to obtain sample greater than 5 mg,Portex cannula compared with silver cannula (transcervical),2.79044447924919,negative,negative,negative,negative.,"negative, as it indicates","negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9889749760050592,"negative
",neg,neg,negative.,neg,negative,neg,0.547407439926323,0.9113596451083292, negative,"negative 
",neg,neg,0.9808746816262268,0.580817359316392,negative. the,negative,neg,neg,negative,neg,0.4291076236072819,0.9915356788853642,0.9977245962736536,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
92,CD000115,Boyer 1986,STD-Boyer-1986 0.138 0.342 85 79,-2.28968168815814,0.434313295476939,164,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1983.0,Infant colonisation with Group B strep,Intrapartum antibiotics for Group B streptococcal colonisation,-5.27195854237835,negative,negative,negative,negative.,"negative, as infant","negative.

infant colon",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9963214058662936,"negative
",neg,neg,negative.,neg,negative,neg,0.4499164595492359,0.8111793067036712, negative,"negative 
",neg,neg,0.9668510990441423,0.6801828502463229,positive.,positive,pos,pos,negative,neg,0.3291825319313419,0.76418648522425,0.9116175446508414,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,pos,neg,neg
93,CD000116,Amer-Wahlin 2001,STD-Amer_x002d_Wahlin-2001 0.919 0.092 2519 2447,-0.0926274659089659,0.100741924666464,4966,Pregnancy & Childbirth,efficacy,DICH,1,1,no,2001.0,Caesarean section,Fetal ECG plus CTG versus CTG alone,-0.919453010408887,negative,negative,negative,neutral.,negative,"negative.

a caes",neg,negative,neg,neg,neu,neg,neg,neg,neg,"negative
",negative,0.997468316529763,"neutral
",neg,neu,negative.,neg,negative,neg,0.437795578259005,0.6842001005713546, negative,"negative 
",neg,neg,0.8641027994545538,0.7935083826791018,positive.,positive,pos,pos,negative,neg,0.4121661652597037,0.7578088210902069,0.9737469552546772,neg,neg,neu,neg,neg,neg,neg,neg,neu,neg,neg,neg,pos,pos,neg,neg
94,CD000117,Burma 1976,STD-Burma-1976 0.055 0.616 30 25,-4.34267547823064,1.47942858030606,55,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1976.0,Low pre delivery haemoglobin,Routine iron versus no iron or placebo in pregnancy,-2.93537351923553,negative,negative,negative,negative.,negative,"negative.

low pre",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9987934426763122,"negative
",neg,neg,negative.,neg,negative,neg,0.5219089263106604,0.9529751972051638, negative,"negative 
",neg,neg,0.9971978725938258,0.7535620132742069,negative.,negative,neg,neg,negative,neg,0.5162521385643122,0.993195423098144,0.9998361140890487,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
95,CD000118,Mardones 1988,STD-Mardones-1988 1.61 0.147 391 391,0.479798026838023,0.148510276741171,782,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1988.0,SGA birth,Isocaloric balanced protein supplementation in pregnancy,3.2307395647389,negative,negative,negative,negative.,negative,"negative.

sga",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9956682701235468,"negative
",neg,neg,negative.,neg,negative,neg,0.3912655485156834,0.8967325110562324, negative,"negative 
",neg,neg,0.9923646224384328,0.5540376760153335,negative. s,negative,neg,neg,negative,neg,0.34935148257487564,0.987064834372199,0.999447651013234,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
96,CD000120,Crawford 1972,STD-Crawford-1972 0.528 0.509 61 86,-0.690403694614195,0.555408723299523,147,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1972.0,low Apgar score (as defined by authors),Lateral tilt vs supine position for Caesarean,-1.24305518738112,negative,negative,negative,negative.,negative,"negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9969242595112252,"negative
",neg,neg,negative.,neg,negative.,neg,0.6621636805808279,0.9354733030061144, negative,"negative 
",neg,neg,0.9971957388782434,0.607262438587839,negative.,negative,neg,neg,negative,neg,0.43135205743715516,0.9782781541039846,0.9995139816437811,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
97,CD000121,Dahle 1995,STD-Dahle-1995 0.18 0.611 34 35,-2.06576143777575,0.815285460487115,69,Pregnancy & Childbirth,efficacy,DICH,1,5,no,1995.0,women with persisting leg cramps,Magnesium versus placebo,-2.53378913017964,negative,negative,negative,negative.,"positive, as it","negative.

leg cramps",neg,negative,neg,neg,neg,pos,neg,neg,neg,"negative
",negative,0.9949391544498948,"negative
",neg,neg,positive.,pos,negative,neg,0.4214567528460013,0.8156300313660287, neutral,"positive 
",neu,pos,0.8314011398573198,0.6514094096483221,positive.,positive,pos,pos,neutral,neu,0.34061806771858594,0.73566817599902,0.8857703103925286,neg,neg,neg,pos,pos,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg
98,CD000122,Braz 2006,STD-Braz-2006 1.002 0.157 95 93,0.0031868909285189,0.292559275734023,188,Neonatal,efficacy,DICH,1,1,yes,1997.0,"Acute ROP, all infants < 2001 g birth weight",Reduced light versus controls,0.0108931460830394,negative,negative,negative,negative.,"negative, since acute","negative.

acute r",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.997110053458395,"negative
",neg,neg,negative.,neg,negative,neg,0.5930417713149825,0.9501526570593384, negative,"negative 
",neg,neg,0.9956582573219414,0.6036858236112311,negative.,negative,neg,neg,negative,neg,0.2724206211860114,0.9639849902907175,0.9990826922849118,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
99,CD000123,Castano 1999,STD-Castano-1999 0.187 1.57 31 31,-1.67503519491991,1.57023703205305,62,Heart & Hypertension,efficacy,DICH,1,1,no,1999.0,All-cause mortality,Any lipid-lowering regimen vs control: all trials,-1.06674034602906,negative,negative,negative,negative.,negative. a lower all,"negative.

all-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9481547724261624,"negative
",neg,neg,negative.,neg,negative.,neg,0.5099669888207438,0.6938438265755528, negative,"negative 
",neg,neg,0.7769481340429605,0.6676637309478661,positive,negative,pos,neg,negative,neg,0.24511514534648524,0.8273269502514793,0.9994927834293589,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
100,CD000126,Forssell 1989,STD-Forssell-1989 1.973 0.836 56 55,0.71219537553064,0.887749229095171,111,Neurology,efficacy,DICH,1,1,yes,1989.0,Any stroke within 30 days of operation,Local versus general anaesthetic: randomised trials,0.802248373965401,negative,negative,negative,negative.,negative,"negative.

a stroke",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9987356485666372,"negative
",neg,neg,negative.,neg,negative.,neg,0.5922041905277746,0.9357740502511672, negative,"negative 
",neg,neg,0.9902845111396802,0.5890011082436285,positive.,negative,pos,neg,negative,neg,0.3987316857391955,0.7727762874071673,0.9987738878845434,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
101,CD000127,Bangladesh 1998,STD-Bangladesh-1998 0.429 0.675 100 100,-0.889409345737331,0.70516128843906,200,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1998.0,Maternal death,Magnesium sulphate versus diazepam,-1.26128498588759,negative,negative,negative,negative.,negative,"negative.

maternal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9972846882458376,"negative
",neg,neg,negative.,neg,negative,neg,0.7605127025546636,0.8051368450149878, negative,"negative 
",neg,neg,0.9769139852143964,0.5859563637098578,negative.,negative,neg,neg,negative,neg,0.4973373030262357,0.9050609406249487,0.9996691844880347,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
102,CD000128,Brazil 2003,STD-Brazil-2003 0.254 1.616 41 31,-1.4065790322914,1.65031813219595,72,Pregnancy & Childbirth,efficacy,DICH,1,4,no,2003.0,Pulmonary oedema,Magnesium sulphate vs phenytoin (subgroup by IV or IM magnesium maintenance),-0.852307809537164,negative,negative,negative,negative.,negative,"negative.

pulmonary",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.998812114395334,"negative
",neg,neg,negative.,neg,negative.,neg,0.6576102540021428,0.891145555480007, negative,"negative 
",neg,neg,0.9902815884566716,0.5213185780151596,the outcome ',negative,neg,neg,negative,neg,0.393421639469263,0.9384789280289317,0.9997976235963071,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
103,CD000129,CS Burkina Faso 1988,STD-CS-Burkina-Faso-1988 1.77 0.478 35 35,0.583251509736728,0.486576517461481,70,Infectious Diseases,efficacy,DICH,1,2,no,1988.0,New malaria infection,CS-NANP vaccine versus placebo,1.19868404825537,negative,negative,negative,negative.,negative,"negative.

new malaria",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9985673029916744,"negative
",neg,neg,negative.,neg,negative,neg,0.6361387707022835,0.7482340269162002, negative,"negative 
",neg,neg,0.9283728409808478,0.6920817454313525,positive.,negative.,pos,neg,negative,neg,0.3376935842393531,0.7581153768234323,0.9991987216687591,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
104,CD000132,Chandra 1986,STD-Chandra-1986 0.399 0.564 35 36,-0.970778917158225,0.603524998854583,71,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1986.0,Incidence of atopic eczema in first 12-18 months,Maternal antigen avoidance during lactation in women at high risk for atopic offspring,-1.60851484031423,negative,negative,negative,negative.,"negative, because at","negative.

a higher",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9953178024235771,"negative
",neg,neg,negative.,neg,negative,neg,0.4471913582185552,0.6633878658812766, negative,"negative 
",neg,neg,0.6075585731869582,0.7124948591508168,neutral. the,negative,neu,neg,negative,neg,0.3540079824655683,0.5003695651471265,0.9936196425630915,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neu,neg,neg,neg
105,CD000133,Falth-Magnusson 1987,STD-Falth_x002d_Magnusson-1987 1.31 0.263 76 95,0.361601062274788,0.353702735507693,171,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Atopic eczema in first 12-18 months,Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring,1.02233040905312,negative,negative,negative,negative.,negative,"negative.

atopic",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991573288069548,"negative
",neg,neg,negative.,neg,negative,neg,0.417951885755368,0.8888192895663666, negative,"negative 
",neg,neg,0.9706435168465742,0.5793258999406422,the outcome ',positive,neg,pos,negative,neg,0.2743978294379877,0.8942896781487192,0.9994325283456534,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg
106,CD000135,New Guinea 1971,STD-New-Guinea-1971 0.73 0.147 498 534,-0.373548629625477,0.173389555153407,1032,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1991.0,Death during infancy and early childhood,Iodine supplementation versus no supplementation,-2.15438945728294,negative,negative,negative,negative.,negative,"negative.

death during",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9966231649753536,"negative
",neg,neg,negative.,neg,negative.,neg,0.8161760062688197,0.7862936929067035, negative,"negative 
",neg,neg,0.9723743074157322,0.5341192072050032,negative.,negative,neg,neg,negative,neg,0.3612910499107994,0.918204202088549,0.9997407870116447,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
107,CD000136,Thorp 1995,STD-Thorp-1995 1.073 1.397 41 44,0.0723206615796261,1.43117288052614,85,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1995.0,Assisted vaginal delivery,Prophylactic maternal oxygen,0.0505324427004507,neutral,positive,positive,positive.,"neutral

","positive.

assisted vaginal",neg,negative,pos,pos,pos,neu,pos,neg,neu,"negative
",negative,0.9743793975300358,"negative
",neg,neg,positive.,pos,positive,pos,0.4647999367279875,0.35567329994884," neutral

","positive 
",neu,pos,0.6182862580110446,0.6295993541227604,positive. ass,positive,pos,pos,neutral,neu,0.3597612479441151,0.7134959380455668,0.9724675301228862,pos,pos,pos,neu,pos,pos,pos,neg,neg,neu,pos,neu,pos,pos,neu,neg
108,CD000137,Battaglia 1992,STD-Battaglia-1992 0.43 0.407 17 19,-1.64865862558738,0.72589467343622,36,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1992.0,Perinatal mortality,Maternal oxygen therapy versus no treatment,-2.27120915184982,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9942692756065412,"negative
",neg,neg,negative.,neg,negative.,neg,0.4287172689923976,0.8672185048283859, negative,"negative 
",neg,neg,0.957838412095449,0.5618403135242415,the outcome ',negative,neg,neg,negative,neg,0.33624810719252446,0.9744754262910172,0.9999283603516352,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
109,CD000138,Ohrt 1997,STD-Ohrt-1997 0.04 0.35 68 69,-6.09630219882355,1.44703012737714,137,Infectious Diseases,efficacy,DICH,1,1,no,1997.0,Smear positive malarial illness,Mefloquine versus placebo or no drug,-4.212975309556,negative,negative,negative,negative.,"negative, because being","positive.

smear",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.996776932968174,"negative
",neg,neg,negative.,neg,negative,neg,0.5733818580296649,0.4094321202926586, negative,"positive 
",neg,pos,0.932488107386736,0.7348118825038598,positive.,positive,pos,pos,negative,neg,0.5851605283560556,0.7568230637860199,0.9987740068314034,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg,pos,neg,pos,pos,neg,neg
110,CD000139,Barrington 1993,STD-Barrington-1993 1.5 0.796 10 10,0.538996500732687,1.04937623195424,20,Neonatal,efficacy,DICH,1,1,yes,1993.0,Failed extubation,Methylxanthine vs control - all preterm infants,0.513635133253324,negative,negative,negative,negative.,negative,"negative.

failed ext",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9995955868370572,"negative
",neg,neg,negative.,neg,negative,neg,0.8185585895925009,0.9511426164996456, negative,"negative 
",neg,neg,0.9465641852998472,0.6683504231284767,negative.,negative,neg,neg,negative,neg,0.5267586590399469,0.9855818000202017,0.9992008640322413,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
111,CD000140,Erenberg 2000,STD-Erenberg-2000 0.576 0.269 45 37,-0.957448804367663,0.460988248609946,82,Neonatal,efficacy,DICH,1,1,no,2000.0,Failed apnoea reduction after 2 - 7 days,Any methylxanthine vs control,-2.07694839782735,negative,negative,negative,negative.,negative,"negative.

reduced ap",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9984267064259684,"negative
",neg,neg,negative.,neg,negative,neg,0.7493878019354719,0.9221800457611482, negative,"negative 
",neg,neg,0.9978166908567728,0.5309516286106327,negative. the,negative,neg,neg,negative,neg,0.6735785091219489,0.9771095928799847,0.9986534394256177,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
112,CD000141,Corbet 1995,STD-Corbet-1995 0.816 0.182 416 410,-0.233693762209362,0.208885167110868,826,Neonatal,efficacy,DICH,1,1,no,1995.0,Pneumothorax,Multiple vs single dose surfactant for severe RDS,-1.1187666670718,negative,negative,negative,negative.,negative,"negative.

pne",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9994207566662312,"negative
",neg,neg,negative.,neg,negative,neg,0.7378750133479675,0.9084687668692754, negative,"negative 
",neg,neg,0.981983063389093,0.68372112641262,the outcome ',negative,neg,neg,negative,neg,0.2915385120324725,0.9366454612463088,0.9997895207110944,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
113,CD000143,Annibale 1994,STD-Annibale-1994 0.926 0.277 40 42,-0.125163142954006,0.45331026469564,82,Neonatal,efficacy,DICH,1,1,yes,1994.0,Failure,Nasal CPAP vs Headbox,-0.276109218568087,negative,negative,negative,negative.,negative,"negative.

failure of",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998644850129856,"negative
",neg,neg,negative.,neg,negative,neg,0.7566803937678815,0.924511928174115, negative,"negative 
",neg,neg,0.9808630965515158,0.5923333251295795,the outcome ',negative,neg,neg,negative,neg,0.4241486647332189,0.973558452842867,0.9997803455340087,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
114,CD000144,Ainsworth 2000,STD-Ainsworth-2000 0.456 0.289 99 100,-1.00347462676294,0.360477593548117,199,Neonatal,efficacy,DICH,1,1,no,2000.0,Mortality,Animal derived surfactant extract versus protein free synthetic surfactant,-2.78373647828127,negative,negative,negative,negative.,negative,"negative.

mortality is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9982724927613152,"negative
",neg,neg,negative.,neg,negative.,neg,0.63628520337485,0.8208306011372226, negative,"negative 
",neg,neg,0.9867348594287672,0.7990081174537574,the outcome ',negative,neg,neg,negative,neg,0.5587457083418516,0.9903333799725837,0.9997710513900582,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
115,CD000145,Carlsson 2000,STD-Carlsson-2000 0.233 0.759 17 16,-1.45528723260684,0.75907211527659,33,Pregnancy & Childbirth,efficacy,DICH,1,14,no,2000.0,Effect on persistent vomiting,Acupuncture or acupressure for hyperemesis gravidarum,-1.91719232378411,positive,negative,negative,negative,positive,"negative.

persistent vomiting",neg,negative,neg,neg,neg,pos,neg,neg,pos,"negative
",negative,0.9990506780614548,"negative
",neg,neg,positive.,pos,negative,neg,0.5506342651255229,0.3370352326256604, neutral,"positive 
",neu,pos,0.4617928260354136,0.8714834792996671,positive.,positive,pos,pos,negative,neg,0.4300119223907906,0.8431290585861139,0.9519406928113456,neu,neg,neg,pos,pos,neg,neg,neg,neg,neu,pos,neu,pos,pos,neg,neg
116,CD000146,Abelin 1989,STD-Abelin-1989 1.53 0.36 100 99,0.493814277939454,0.416106295861498,199,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1989.0,Smoking cessation at 6+ months follow up,Any type of NRT versus placebo/no NRT control,1.18675031560643,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9915538662100156,"positive
",pos,pos,positive.,pos,positive,pos,0.4356690096556701,0.7066855218543613, positive,"positive 
",pos,pos,0.99509156974545,0.8286577070552297,positive.,positive,pos,pos,positive,pos,0.52504455747593,0.5260060083229682,0.9981674222057504,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
117,CD000148,Herre 1976,STD-Herre-1976 0.536 0.514 16 15,-0.965080896043587,0.775364737520656,31,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1976.0,Low weight for gestational age (< 5th centile),Calf blood extract versus placebo,-1.24467988978913,negative,negative,negative,negative.,negative,"negative.

low weight",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9990890052379156,"negative
",neg,neg,negative.,neg,negative,neg,0.6182132202089748,0.9467606482305352, negative,"negative 
",neg,neg,0.9850306850366152,0.5345793397727112,negative.,negative,neg,neg,negative,neg,0.4180346511935274,0.9857394243015424,0.9992973975842939,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg
118,CD000149,Kafatos 1989,STD-Kafatos-1989 1.007 0.37 265 250,0.0066711388170221,0.370726381678767,515,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Small for gestational age,Nutritional advice during pregnancy,0.0179947776762288,negative,negative,negative,negative.,negative,"negative.

small for",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997387536307772,"negative
",neg,neg,negative.,neg,negative.,neg,0.4404426310338168,0.9415392312450204, negative,"negative 
",neg,neg,0.9723204333014436,0.6326589704015751,positive.,negative,pos,neg,negative,neg,0.3660487819854268,0.9671906536140262,0.9995385154874427,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,neg,pos,neg,neg,neg
119,CD000150,Aafjes 1983,STD-Aafjes-1983 2.513 0.857 27 32,0.958850346292951,0.909291809158588,59,Gynaecology & Urology,efficacy,DICH,1,1,no,1983.0,pregnancy rate (per patient),Androgens with stimulatory effect versus no treatment/placebo,1.05450234637022,positive,positive,positive,positive,positive,"positive.

pregnancy rate",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9950172905871582,"positive
",pos,pos,negative.,neg,positive.,pos,0.4456482417871044,0.4566251285606034, positive,"positive 
",pos,pos,0.7960263115227814,0.937509588077088,the outcome ',positive,neg,pos,neutral,neu,0.31494218952170117,0.992668535868676,0.9239776172490562,pos,pos,pos,pos,neg,pos,pos,pos,pos,pos,pos,pos,neg,pos,neu,neg
120,CD000151,Ainmelk 1987,STD-Ainmelk-1987 7.898 1.438 16 16,1.73864964391411,1.59046269300711,32,Gynaecology & Urology,efficacy,DICH,1,1,no,1987.0,pregnancy,Anti-oestrogens versus placebo/no treatment,1.09317222689884,positive,negative,positive,positive,positive (note: in,"negative.

pregnancy is",pos,negative,neg,pos,pos,pos,neg,neg,pos,"positive
",positive,0.9904299977407924,"positive
",pos,pos,negative.,neg,negative.,neg,0.5106837528572563,0.7842121126948467, neutral,"positive 
",neu,pos,0.5713302475926673,0.8168281604439122,positive.,positive,pos,pos,neutral,neu,0.40654693910199985,0.9745714317608005,0.8101939513441268,neg,pos,pos,pos,neg,neg,neg,pos,pos,pos,pos,neu,pos,pos,neu,neg
121,CD000152,Hovatta 1979,STD-Hovatta-1979 0.441 1.189 20 18,-0.864997437486604,1.27087827070391,38,Gynaecology & Urology,efficacy,DICH,1,1,no,1979.0,pregnancy rate (per patient),Bromocriptine versus placebo/no treatment,-0.680629653859374,positive,positive,positive,positive,positive,"positive.

pregnancy rate",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9968013253949528,"positive
",pos,pos,negative.,neg,neutral,neu,0.4614743065652295,0.4647988562640736, positive,"positive 
",pos,pos,0.4617621091600006,0.9337564088007988,positive.,positive,pos,pos,neutral,neu,0.3764713041106674,0.9829519176791455,0.9772169319532921,pos,pos,pos,pos,neg,neu,pos,pos,pos,pos,pos,pos,pos,pos,neu,neg
122,CD000153,Izzo 1984,STD-Izzo-1984 7.426 1.441 15 14,1.68089687641625,1.59469106453741,29,Gynaecology & Urology,efficacy,DICH,1,1,no,1984.0,Pregnancy rate (per patient),Kinin enhancing drugs versus placebo/no treatment,1.05405800144986,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9971467988374484,"positive
",pos,pos,negative.,neg,neutral,neu,0.4806014026229776,0.5148822485400886, positive,"positive 
",pos,pos,0.6231219063526738,0.944239537632361,positive.,positive,pos,pos,neutral,neu,0.38431884904772307,0.9750627305902054,0.9466547678106976,pos,pos,pos,pos,neg,neu,pos,pos,pos,pos,pos,pos,pos,pos,neu,neg
123,CD000154,Agarwal 2016,STD-Agarwal-2016 0.37 0.588 25 25,-0.994933859193268,0.588354647937302,50,Gynaecology & Urology,efficacy,DICH,1,4,yes,2016.0,Response to treatment,COCP versus CVR,-1.6910444451852,positive,positive,positive,positive.,the term 'response to treatment,"positive.

response to",pos,negative,pos,pos,pos,neg,pos,neg,pos,"positive
",positive,0.7177465619720709,"positive
",pos,pos,positive.,pos,positive,pos,0.5050834787106687,0.7413673652455126," positive
","positive 
",pos,pos,0.9027022505565396,0.9261496641263696,the outcome ',positive,neg,pos,neutral,neu,0.41856706344245387,0.5438360292646722,0.844207843403335,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg,pos,neu,neg
124,CD000155,Bayer 1988,STD-Bayer-1988 0.611 0.473 37 36,-0.501878837776184,0.479629911440974,73,Gynaecology & Urology,efficacy,DICH,1,1,no,1988.0,Clinical pregnancy,Ovulation suppression versus placebo,-1.04638769560549,positive,positive,positive,positive,"negative, because the","positive.

clinical pregnancy",pos,negative,pos,pos,pos,neg,pos,neg,pos,"positive
",positive,0.9980848465512092,"positive
",pos,pos,positive.,pos,positive,pos,0.3936503175852691,0.6023928125968212, positive,"positive 
",pos,pos,0.8164661086417991,0.8196009901775149,positive.,positive,pos,pos,positive,pos,0.48426948040903234,0.5037676663471401,0.9955504920057944,pos,pos,pos,neg,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,pos,neg
